We demonstrated that regulation of pyrimidine synthesis by the β-catenin/AKT2 cascade still exists in MEFs, which lacks GS enzymatic activity, in S6K-depleted liver cancer cells, and in Tsc2 null cells where potential activation of β-catenin/AKT2 on S6K is disconnected. This evidence concerns the gene AKT2 and liver cancer.